Skip to search formSkip to main contentSkip to account menu

Thrombolytic Therapy

Known as: Therapies, Fibrinolytic, Therapy, Fibrinolytic, fibrinolytics 
Use of infusions of FIBRINOLYTIC AGENTS to destroy or dissolve thrombi in blood vessels or bypass grafts.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2009
Review
2006
Review
2006
Pregnancy due to its physiological changes is a procoagulant state. The rate of cardiac valve prosthesis thrombosis, deep venous… 
Highly Cited
2003
Highly Cited
2003
BACKGROUND For the treatment of myocardial infarction with ST-segment elevation, primary angioplasty is considered superior to… 
Highly Cited
1999
Highly Cited
1999
Kenneth W. Mahaffey, MD, FACC, Joseph A. Puma, DO, N. Alejandro Barbagelata, MD,* Marcelo F. DiCarli, MD,† Massoud A. Leesar, MD… 
Review
1998
Review
1998
Clinical trials of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors or statin therapy have demonstrated that… 
Review
1996
Review
1996
In 1994 a panel of the American Heart Association Stroke Council wrote guidelines on the management of patients with acute… 
Highly Cited
1994
Highly Cited
1994
Indirect evidence suggests a crucial role for the fibrinolytic system and its physiological triggers, tissue-type (t-PA) and… 
Highly Cited
1983
Highly Cited
1983
Bacterial clones containing human tissue-type plasminogen activator (t-PA) cDNA sequences were identified in a cDNA library…